Cardone Ventures, a business growth and investment firm, has announced the UK launch of the patented 10X Precision Nutrition System.
This new system, touted to be the world’s first, is introduced in partnership with REVIV Global, a personalised health and IV therapy provider.
The launch, announced in April 2024, marks the first international expansion of Cardone Ventures’ portfolio company, 10X Health, outside the US. It also advances personalised health solutions.
The collaboration combines REVIV’s expertise in IV therapy with 10X Health’s advanced genetic technology to introduce a new way for health optimisation based on everyone’s genetic makeup.
The UK launch marks the first step in a strategic international expansion, with plans to roll out to additional key global markets.
Cardone Ventures and 10X Health CEO Brandon Dawson said: “By combining 10X’s precision genetic technology with REVIV’s proven expertise in personalised and precision health solutions, we’re delivering an unparalleled system that empowers individuals to optimise their health with unmatched accuracy and accessibility.”
According to Cardone Ventures, the 10X Precision Genetic Test uses advanced technology and artificial intelligence (AI) to analyse up to 20 million genetic variations with 99.97% accuracy.
Developed by biotechnologist Daniel Wallerstorfer, this system is designed to advance precision health science.
The process is said to be simple and non-invasive. Customers submit an oral swab, which is analysed at a lab using Micro Array technology to capture 700,000 DNA variations.
AI-powered bioinformatics then expands the analysis, providing a detailed report within six weeks.
The comprehensive 400+ page report offers detailed insights into nutrition, weight management, and lifestyle factors.
It covers areas such as caffeine consumption and absorption, inflammation and immune system performance, salt sensitivity and blood pressure, fat distribution, and muscle preservation, among many other key health aspects.
With their results in hand, customers gain access to personalised health tools, including 10X Precision Supplements, custom-formulated micro-bead supplements designed for optimal absorption and bioavailability.
These supplements improve digestion, immunity, skin health, energy levels, and metabolic function.
Additionally, 10X Precision IV Drip Therapy, the only IV therapy tailored to an individual’s unique genetic profile, offers personalised wellness.
REVIV global CEO Sarah Lomas said: “This partnership eradicates the guesswork of health fads and trends, replacing them with science-backed, data-driven solutions that uniquely cater to each individual.”
